Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2021 5
2022 8
2023 4
2024 6
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
FGFR1 wild-type rosette-forming glioneuronal tumours.
Le Quang M, Trinquet A, Siegfried A, de Barros A, Bauchet L, Ng S, Jecko V, Chotard G, Ollivier M, Adam G, Bonneville F, Masliah-Planchon J, Nicaise Y, Decamps C, Rigau V, Uro-Coste E. Le Quang M, et al. Among authors: chotard g. Acta Neuropathol. 2024 Aug 21;148(1):26. doi: 10.1007/s00401-024-02779-x. Acta Neuropathol. 2024. PMID: 39167187 Free PMC article. No abstract available.
Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours.
Appay R, Bielle F, Sievers P, Barets D, Fina F, Boutonnat J, Adam C, Gauchotte G, Godfraind C, Lhermitte B, Maurage CA, Meyronet D, Mokhtari K, Rousseau A, Tauziède-Espariat A, Tortel MC, Uro-Coste E, Burel-Vandenbos F, Chotard G, Pesce F, Varlet P, Colin C, Figarella-Branger D. Appay R, et al. Among authors: chotard g. Neuropathol Appl Neurobiol. 2022 Aug;48(5):e12813. doi: 10.1111/nan.12813. Epub 2022 Mar 23. Neuropathol Appl Neurobiol. 2022. PMID: 35293634
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.
Kacimi SEO, Dehais C, Feuvret L, Chinot O, Carpentier C, Bronnimann C, Vauleon E, Djelad A, Cohen-Jonathan Moyal E, Langlois O, Campone M, Ducloie M, Noel G, Cuzzubbo S, Taillandier L, Ramirez C, Younan N, Menei P, Dhermain F, Desenclos C, Ghiringhelli F, Bourg V, Ricard D, Faillot T, Appay R, Tabouret E, Nichelli L, Mathon B, Thomas A, Tran S, Bielle F, Alentorn A, Iorgulescu JB, Boëlle PY, Labreche K, Hoang-Xuan K, Sanson M, Idbaih A, Figarella-Branger D, Ducray F, Touat M; POLA Network. Kacimi SEO, et al. J Clin Oncol. 2025 Jan 20;43(3):329-338. doi: 10.1200/JCO.24.00049. Epub 2024 Oct 2. J Clin Oncol. 2025. PMID: 39356975
Intramedullary Spinal Cord Lesions: A Single-Center Experience.
Jecko V, Roblot P, Mongardi L, Ollivier M, Piccoli ND, Charleux T, Wavasseur T, Gimbert E, Liguoro D, Chotard G, Vignes JR. Jecko V, et al. Among authors: chotard g. Neurospine. 2022 Mar;19(1):108-117. doi: 10.14245/ns.2143190.595. Epub 2022 Mar 31. Neurospine. 2022. PMID: 35378585 Free PMC article.
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.
Esparragosa Vazquez I, Sanson M, Chinot OL, Fontanilles M, Rivoirard R, Thomas-Maisonneuve L, Cartalat S, Tabouret E, Appay R, Bonneville-Levard A, Darlix A, Meyronet D, Barritault M, Gueyffier F, Remontet L, Maucort-Boulch D, Honnorat J, Dehais C, Ducray F; POLA Network. Esparragosa Vazquez I, et al. Neurooncol Adv. 2024 May 27;6(1):vdae078. doi: 10.1093/noajnl/vdae078. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38855053 Free PMC article.
[Diagnosis of chronic visual impairment].
Vignal-Clermont C, Chotard G, Chassery M, Atia R, Hajjar S, Villaret J, Pâques M. Vignal-Clermont C, et al. Among authors: chotard g. Rev Prat. 2022 Feb;72(2):217-225. Rev Prat. 2022. PMID: 35289538 French. No abstract available.
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.
Suwala AK, Stichel D, Schrimpf D, Maas SLN, Sill M, Dohmen H, Banan R, Reinhardt A, Sievers P, Hinz F, Blattner-Johnson M, Hartmann C, Schweizer L, Boldt HB, Kristensen BW, Schittenhelm J, Wood MD, Chotard G, Bjergvig R, Das A, Tabori U, Hasselblatt M, Korshunov A, Abdullaev Z, Quezado M, Aldape K, Harter PN, Snuderl M, Hench J, Frank S, Acker T, Brandner S, Winkler F, Wesseling P, Pfister SM, Reuss DE, Wick W, von Deimling A, Jones DTW, Sahm F. Suwala AK, et al. Among authors: chotard g. Acta Neuropathol. 2021 Jul;142(1):179-189. doi: 10.1007/s00401-021-02302-6. Epub 2021 Apr 19. Acta Neuropathol. 2021. PMID: 33876327 Free PMC article.
[Corneal perforations in patients on tyrosine kinase inhibitors].
Amar J, El Kaim P, Scemla B, Boumendil J, Chotard G, Gabison E, Bouheraoua N. Amar J, et al. Among authors: chotard g. J Fr Ophtalmol. 2023 Nov;46(9):1111-1113. doi: 10.1016/j.jfo.2023.03.004. Epub 2023 Jun 23. J Fr Ophtalmol. 2023. PMID: 37357065 French. No abstract available.
Fluorescein and OCT Angiography Features of Takayasu Disease.
Chotard G, Diwo E, Coscas F, Butel N, Saadoun D, Bodaghi B. Chotard G, et al. Ocul Immunol Inflamm. 2019;27(5):774-780. doi: 10.1080/09273948.2018.1455876. Epub 2018 Apr 19. Ocul Immunol Inflamm. 2019. PMID: 29672194
The full range of ophthalmological clinical manifestations in systemic lupus erythematosus.
Kedia N, Theillac V, Paez-Escamilla M, Indermill C, Gallagher DS, Adam R, Qu-Knafo AL, Amari F, Bottin C, Chotard G, Caillaux V, Strého M, Sedira N, Héron E, Becherel PA, Bodaghi B, Mrejen-Uretski S, Sahel AJ, Saadoun D, Errera MH. Kedia N, et al. Among authors: chotard g. Front Ophthalmol (Lausanne). 2023 Jan 26;2:1055766. doi: 10.3389/fopht.2022.1055766. eCollection 2022. Front Ophthalmol (Lausanne). 2023. PMID: 38983519 Free PMC article.
23 results